Michie, and Maheshwari did not disclose any financial relationships relevant to this article. Objectives After completing this article, readers should be able to: 1. Define key neutrophil functions and involved mechanisms. 2. Identify developmental defects in preterm neutrophils. 3. Describe the effect on neutrophils of clinical interventions, such as the use of recombinant myeloid growth factors and drugs commonly used in the neonatal intensive care unit.
AbstractNeutrophil development starts in the early second trimester in the human fetus and continues through the rest of the gestation. Preterm birth can interrupt the maturation of fetal neutrophils and place the preterm neonate at risk of life-threatening infections. Various developmental defects have been identified in preterm neutrophils, such as in the ability of circulating neutrophils to cross the endothelial barrier and abnormalities in chemotaxis, respiratory burst, and degranulation. The availability of recombinant human myeloid growth factors has renewed interest in understanding the mechanisms and natural history of such defects. In this article, we review various aspects of the developmental immaturity of preterm neutrophils.